Skip to main content

Immunotherapy in colorectal cancer, the future is now?

Intervista a Myriam Chalabi By 5 Dicembre 2022No Comments

After the groundbreaking data presented by Andrea Cercek at ASCO 2022 and then at ESMO 2022 from NICHE-2 trial, what should we expect from ongoing investigations in neoadjuvant immunotherapy of colorectal cancer? We asked Myriam Chalabi (Gastrointestinal Oncology – Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam) we met at Immunotherapy Bridge Congress 2022 in Naples.